Tumor microenvironment-responsive dynamic self-assembly of DNAzyme nanowires for high-contrast imaging of multiple messenger RNAs and chemotherapy
Biosensors and Bioelectronics · 2025
DOI: 10.1016/j.bios.2025.117728 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025. Verfasst von Huimin Yuan und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, State Key Laboratory of Digital Medical Engineering, Southeast University, Nanjing, 211189, China. Hauptthemen laut MEDLINE: DNA, Catalytic, RNA, Messenger, Nanowires, Doxorubicin. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Messenger RNAs (mRNAs) are a category of protein-coding RNA, and their dysregulation is closely implicated in diverse cancers. Static DNA nanodevices have been engineered for the imaging and therapy, but they rely on the pre-assembly of DNA components and are limited by the low imaging contrast. Herein, we demonstrate the tumor microenvironment-responsive dynamic self-assembly of DNAzyme nanowires for high-contrast imaging of multiple mRNAs and chemotherapy. We design a cruciform DNA module (C-model) as a basic structural unit of DNAzyme nanowire, which consists of two DNAzyme strands and two substrate strands with the chemotherapeutic drug doxorubicin (DOX) being inserted into the C-models by inlaying between guanine and cytosine. Once approaching tumor cells, C-models with two split i-motif spontaneously assemble into a DNAzyme nanowire through protonation-driven Hoogsteen interaction in response to extracellular acidic microenvironments. Upon the internalization, intracellular TK1 mRNA and GalNAc-T mRNA hybridize with the overhangs of DNAzyme strands and substrate strands to form a stable DNAzyme/substrate/target three-way junction, inducing the cleavage of substrates by DNAzymes and the recovery of Cy5/Texas Red fluorescence. AS1411 aptamer-functionalized DOX-nanowires can selectively endocytose into cancer cells via AS1411-mediated recognition of nucleolin overexpressed on the cancer cell surface. Notably, the dynamic self-assembly of DNAzyme nanowires is characterized by efficient intracellular delivery and intrinsic resistance to nucleases, facilitating the high-contrast imaging of mRNAs. This method can accurately measure TK1 mRNA and GalNAc-T mRNA in living cells and discriminate multiple mRNAs in breast cancer tissues and their normal counterparts, providing a powerful platform for clinical diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, State Key Laboratory of Digital Medical Engineering, Southeast University, Nanjing, 211189, China.
- School of Chemistry and Chemical Engineering, State Key Laboratory of Digital Medical Engineering, Southeast University, Nanjing, 211189, China. Electronic address: wanglijuan@seu.edu.cn.
- School of Chemistry and Chemical Engineering, State Key Laboratory of Digital Medical Engineering, Southeast University, Nanjing, 211189, China. Electronic address: zhangcy@seu.edu.cn.
Zitieren
APA
Yuan, H., Li, H. J., Wang, L. J., & Zhang, C. Y. (2025). Tumor microenvironment-responsive dynamic self-assembly of DNAzyme nanowires for high-contrast imaging of multiple messenger RNAs and chemotherapy. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.117728
Vancouver
Yuan H, Li HJ, Wang LJ, Zhang CY. Tumor microenvironment-responsive dynamic self-assembly of DNAzyme nanowires for high-contrast imaging of multiple messenger RNAs and chemotherapy. Biosensors and Bioelectronics. 2025. doi:10.1016/j.bios.2025.117728
BibTeX
@article{Yuan2025,
author = {Yuan, Huimin and Li, Hai-Juan and Wang, Li-Juan and Zhang, Chun-Yang},
title = {Tumor microenvironment-responsive dynamic self-assembly of DNAzyme nanowires for high-contrast imaging of multiple messenger RNAs and chemotherapy},
journal = {Biosensors and Bioelectronics},
year = {2025},
doi = {10.1016/j.bios.2025.117728}
}
EUVIMED